SPD Swiss Precision Diagnostics
SPD Swiss Precision Diagnostics is a Geneva-based 50/50 joint venture between Procter & Gamble and Abbott, formed in 2007 and operating under the Clearblue brand to research, design, and market home pregnancy tests, ovulation and fertility monitors, and (in the US) a menopause stage indicator for women globally.
- Company typePrivate
- Founded2007
- HeadquartersGeneva, Switzerland
- Headcount51–100
- GTM typeB2C
- OfferingHardware or Manufacturing
What SPD Swiss Precision Diagnostics does
SPD Swiss Precision Diagnostics GmbH (SPD) is a Geneva-headquartered joint venture formed in 2007 between Procter & Gamble and Abbott, operating under the globally recognized Clearblue brand as a category leader in home reproductive diagnostics. The company researches, designs, and markets consumer diagnostic products for women navigating pregnancy, fertility, and menopause, including digital pregnancy tests with weeks indicator (97% agreement with ultrasound dating), a dual-hormone (E3G + LH) Advanced Fertility Monitor that increases chance of conceiving by up to 89% in the first two cycles, and the Clearblue Menopause Stage Indicator (US only) that combines five serial FSH readings with cycle history through a companion app. Core technology is built on regulated lateral flow immunoassay chemistry combined with embedded digital electronics, with the portfolio protected by 5 granted US utility patents, 2 pending applications, and 12 US design patents.
The business operates as a consumer health products company with a B2C distribution model spanning Europe, North America, and Asia Pacific. Products reach end consumers through three channels: physical retail (pharmacies, supermarkets, and major retail chains), e-commerce and online retail (the fastest-growing channel at 25-30% annual growth in key markets), and regional import/distribution in import-dependent markets such as Mexico. Revenue mechanics combine unit sales of single-use pregnancy and ovulation tests with a razor/blade dynamic in the fertility monitor line, where the handheld reader requires recurring purchase of proprietary disposable test sticks. The company has legal entities in Switzerland (SPD Swiss Precision Diagnostics GmbH), the United Kingdom (SPD Development Company Ltd., housing the Clearblue Innovation Centre R&D function in Bedford), and a sales office in Shanghai (SPD Trading Co. Ltd.) for the China market. SPD is regulated as an in vitro medical device manufacturer under FDA, European IVDR, Health Canada, Australian TGA, Japan PMDA, and Brazil ANVISA frameworks, with MDSAP single-audit compliance.
SPD Swiss Precision Diagnostics firmographics
Firmographics- Name
- SPD Swiss Precision Diagnostics
- Legal name
- SPD Swiss Precision Diagnostics GmbH
- Website
- https://swissprecisiondiagnostics.com
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- SPD Swiss Precision Diagnostics is a Geneva-based 50/50 joint venture between Procter & Gamble and Abbott, formed in 2007 and operating under the Clearblue brand to research, design, and market home pregnancy tests, ovulation and fertility monitors, and (in the US) a menopause stage indicator for women globally.
- Ownership category
- akta.pro rank
SPD Swiss Precision Diagnostics industry classification
Industry- Product category
- Consumer Diagnostics
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Pregnancy, Fertility & Women’s Health Rapid Tests (hCG, ovulation, vaginal infection) (HLAHAOAF)
- akta.pro secondary industries
- Home-Use & OTC Rapid Self-Tests (Consumer POCT kits) (HLAHAOAK), Home Diagnostic & Self-Test OTC Kits (HLAIADAO), Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL), Rapid Antigen/Antibody Lateral Flow Tests (General Platform Category) (HLAHAOAH), Personal Medical Devices & Home Diagnostics (Thermometers, Blood Pressure Monitors, Glucose Meters, Rapid Tests) (CRADAMAK)
Keywords
Where SPD Swiss Precision Diagnostics is headquartered
LocationHeadquarters
- HQ city
- Geneva
- HQ country
- Switzerland
- HQ region
- Europe
Offices3 records
Markets served
SPD Swiss Precision Diagnostics business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- Consumer Diagnostic Hardware Sales: Sale of home pregnancy tests, ovulation/fertility tests, and menopause stage indicators as consumer medical devices through retail and e-commerce channels worldwide.
- Advanced Fertility Monitor System: Sale of handheld fertility monitor devices plus recurring revenue from disposable test sticks required for each testing cycle
Go-to-market motion2 records
Distribution channels3 records
Marketing channels4 records
SPD Swiss Precision Diagnostics product offering
Product offeringCore offering
SPD Swiss Precision Diagnostics manufactures and markets advanced consumer diagnostic products under the Clearblue brand, including home pregnancy tests, ovulation and fertility tests, and a menopause stage indicator. The company combines lateral flow rapid diagnostic technology with digital features and sells globally through retail pharmacies and e-commerce channels.
Product overview
SPD Swiss Precision Diagnostics is a joint venture between Procter & Gamble and Abbott formed in 2007, operating under the Clearblue® brand as a world leader in consumer diagnostic products. The company's product portfolio encompasses three core product lines: (1) Pregnancy Tests including Clearblue® Digital Ultra Early, Ultra Early, Digital Early Detection, Rapid Detection, Flip & Click, and Pregnancy Test with Weeks Indicator; (2) Fertility/Ovulation Tests including Clearblue® Advanced Fertility Monitor, Advanced Digital Ovulation Test, and Digital Ovulation Test; and (3) Menopause Products including Clearblue® Menopause Stage Indicator. The company also offers a companion app for the Menopause Stage Indicator enabling cycle and symptom tracking with personalized reporting. Products are regulated under IVDR (Europe), FDA (US), Health Canada, Australian TGA, Japan's PMDA, and Brazil's ANVISA, with headquarters in Geneva, Switzerland and innovation center in Bedford, UK.
Differentiator
Problem solved
Functional benefit
Brands
- Clearblue: World-renowned brand for accurate home pregnancy and fertility tests, known for accuracy, reliability, and simplicity. The brand has earned a global reputation and was the first to introduce one-step pregnancy test, one minute test, sample sufficiency indicator, digitally displayed results, and Weeks Indicator feature.
Products and services
- Clearblue Digital Ultra Early Pregnancy Test
Quantifiable outcome
- Clearblue Advanced Fertility Monitor increases chance of conceiving by up to 89% in first two cycles of use
- +2 more outcomes
Companies that use SPD Swiss Precision Diagnostics
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
SPD Swiss Precision Diagnostics technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
SPD Swiss Precision Diagnostics partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered minor, core and flagship.
- British IVD Association (BIVDA)minorNational industry association for manufacturers and distributors of in vitro diagnostic products in the UK. Clearblue is a member supporting the industry and regulatory advocacy.
- MedTech EuropeminorEuropean trade association for medical technology. Clearblue is a member supporting regulatory advocacy and industry standards in diagnostic devices.
- National Menopause FoundationcoreCommunity organization for women seeking information and connection about the menopause journey. Partnership supports education and awareness for women transitioning through menopause, aligning with Clearblue's menopause product portfolio expansion.
- March of DimescoreUS-based charity working in prenatal health, premature birth prevention, and infant health. SPD supports through research and education initiatives in reproductive health. March of Dimes educates the public and medical professionals about best practices, supports lifesaving research, and advocates for mums and babies.
- Be My EyescoreMobile app connecting blind and low vision users with sighted volunteers and company representatives through live video connection. Partnership enables blind women to be the first to receive their Clearblue pregnancy or ovulation test result independently through the app's accessibility platform.
- Procter & Gamble (P&G)flagshipP&G is one of two joint venture partners forming SPD Swiss Precision Diagnostics. P&G contributes major consumer goods expertise, household brand reach, and consumer marketing capabilities. The joint venture combines P&G's consumer goods strengths with Abbott's diagnostic technology to bring consumer diagnostic innovation to market globally.
- AbbottflagshipAbbott is one of two joint venture partners forming SPD Swiss Precision Diagnostics. Abbott creates breakthrough products in diagnostics, medical devices, nutrition, and pharmaceuticals. The joint venture combines Abbott's diagnostic technology expertise with P&G's consumer marketing to deliver home diagnostic products.
Scale indicators5 records
Recent moves7 records
Expansion highlights6 records
SPD Swiss Precision Diagnostics competitors and assessment
Company assessmentDirect peers
- Church & Dwight (First Response): Church & Dwight markets the First Response brand of home pregnancy and ovulation tests in North America, making it the most direct branded competitor to Clearblue in the same consumer POCT category with overlapping retail placement and pricing tiers.
- Wondfo: Wondfo is one of the world's largest manufacturers of lateral flow rapid diagnostic tests including pregnancy and fertility kits, serving both consumer and clinical channels globally, with a particularly strong China distribution footprint that competes with SPD's own Chinese sales presence.
- Easy@Home (Clinical Genomics): Easy@Home sells home pregnancy and ovulation tests direct-to-consumer through e-commerce marketplaces, competing head-to-head on price and convenience in the same consumer POCT category Clearblue dominates through retail.
- Prestige Consumer Healthcare (E.P.T.): Prestige markets the E.P.T. home pregnancy test brand, a long-standing direct competitor to Clearblue in the US consumer pregnancy testing category with comparable retail positioning and product positioning around accuracy and ease of use.
Broad incumbents
- QuidelOrtho: QuidelOrtho is a major in vitro diagnostics manufacturer producing a broad portfolio of rapid lateral flow and immunoassay tests across clinical and consumer channels, providing benchmark scale and R&D capabilities across diagnostic categories that overlap with SPD's lateral flow technology base.
- Hologic: Hologic is a women's health-focused diagnostic and medical device company with adjacent franchises in reproductive health (e.g., prenatal screening, NovaBay), making it a broader incumbent in women's reproductive diagnostics that overlaps with SPD's core customer population though via clinical rather than consumer channels.
- bioMérieux: bioMérieux is a large in vitro diagnostics company with broad portfolio capabilities in clinical diagnostics and industrial microbiology, providing reference scale and regulatory infrastructure comparable to what Abbott contributes through the SPD joint venture.
Regional players
- Avalun (Gerhardt Pharma - Prega News): Gerhardt's Prega News is a leading home pregnancy test brand in Germany and parts of Europe, competing directly with Clearblue in regional retail channels and offering similar lateral flow technology with strong pharmacy distribution in the DACH region.
Emerging players
- Ava (Ava Science): Ava sells a connected fertility tracking bracelet that predicts fertile windows via physiological signals, representing a tech-forward emerging alternative to ovulation test strips and competing for the same 'trying to conceive' consumer segment Clearblue's Advanced Fertility Monitor targets.
- Mira (Quanovate): Mira offers a connected at-home hormone tracker that quantitatively measures E3G, LH, and other fertility hormones via disposable test wands and an app, positioning it as an emerging digital alternative to Clearblue's fertility monitor with a recurring-stick revenue model directly analogous to SPD's flagship product.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
SPD Swiss Precision Diagnostics social profiles
Digital presenceSPD Swiss Precision Diagnostics compliance and trust
Trust signalCompliance4 records
SPD Swiss Precision Diagnostics financial estimates
Financial estimateRevenue estimate
Valuation estimate
SPD Swiss Precision Diagnostics leadership team
Management profileNumber of profiles
Profiles1 record
SPD Swiss Precision Diagnostics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SPD Swiss Precision Diagnostics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SPD Swiss Precision Diagnostics
What does SPD Swiss Precision Diagnostics do?
SPD Swiss Precision Diagnostics manufactures and markets advanced consumer diagnostic products under the Clearblue brand, including home pregnancy tests, ovulation and fertility tests, and a menopause stage indicator. The company combines lateral flow rapid diagnostic technology with digital features and sells globally through retail pharmacies and e-commerce channels.
Is SPD Swiss Precision Diagnostics a public or private company?
SPD Swiss Precision Diagnostics is a private company. It is classified as corporate owned and is currently operating.
When was SPD Swiss Precision Diagnostics founded?
SPD Swiss Precision Diagnostics was founded in 2007. It employs 51 to 100 people.
Where is SPD Swiss Precision Diagnostics based?
SPD Swiss Precision Diagnostics is headquartered in Geneva, Switzerland, in the Europe region.
How does SPD Swiss Precision Diagnostics make money?
Two revenue lines are on record. Consumer Diagnostic Hardware Sales are the primary driver. The others are advanced Fertility Monitor System.
Who are SPD Swiss Precision Diagnostics's main competitors?
Direct peers on record are Church & Dwight (First Response), Wondfo, Easy@Home (Clinical Genomics) and Prestige Consumer Healthcare (E.P.T.). Broad incumbents are QuidelOrtho, Hologic and bioMérieux. Avalun (Gerhardt Pharma - Prega News) is listed as a regional player. Emerging players are Ava (Ava Science) and Mira (Quanovate).
Does SPD Swiss Precision Diagnostics have an API?
No public API is recorded for SPD Swiss Precision Diagnostics.
What industry is SPD Swiss Precision Diagnostics in?
SPD Swiss Precision Diagnostics's product category is Consumer Diagnostics. Its primary akta.pro industry code is HLAHAOAF, Pregnancy, Fertility & Women’s Health Rapid Tests (hCG, ovulation, vaginal infection), with a secondary code of HLAHAOAK, Home-Use & OTC Rapid Self-Tests (Consumer POCT kits). Its NAICS code is 325413 and its SIC code is 2835.